Adia Nutrition rebrands as Adia Med in regenerative medicine shift

Adia Med has rebranded from Adia Nutrition, aligning its corporate identity with regenerative medicine, stem cell therapies, and biologics.

The company said the shift supports a strategy aimed at a NASDAQ uplisting, with remaining hurdles centered on shareholder equity and net revenue thresholds.

Adia Med reported $637,145 in revenue in the first nine months of 2025, driven by biologics sales and clinic procedures.